Literature DB >> 2137198

A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleus.

C L Chio1, G F Hess, R S Graham, R M Huff.   

Abstract

Overexpression of the D2 dopamine receptor has been proposed to be part of the pathology of schizophrenia. The isolation of a D2 dopamine receptor clone has assisted the molecular characterization of D2 receptor. We have now isolated an identical rat clone along with two other clones--a second related rat clone (RD-2in) and a homologous bovine clone (BD-2in), both of which contain an insert encoding an additional 29 amino acids relative to the original rat clone (RD-2o). All three clones encode D2 receptor binding sites when expressed in COS-7 cells. The amino-acid insert encoded by D-2in lies in the domain of the receptor believed to interact with the GTP-binding proteins (G proteins) of various signal transduction pathways. By using oligonucleotide probes specific for either D-2o or D-2in RNA transcripts, we have found that the level of expression of the D-2in-encoded form of the receptor is seven times that of the D-2o form in the caudate nucleus, the richest brain source of D2 receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137198     DOI: 10.1038/343266a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  18 in total

Review 1.  Dopamine receptor genes: new tools for molecular psychiatry.

Authors:  H B Niznik; H H Van Tol
Journal:  J Psychiatry Neurosci       Date:  1992-10       Impact factor: 6.186

2.  Differential expression of two distinct forms of mRNA encoding members of a dipeptidyl aminopeptidase family.

Authors:  K Wada; N Yokotani; C Hunter; K Doi; R J Wenthold; S Shimasaki
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

3.  Another mechanism for creating diversity in gamma-aminobutyrate type A receptors: RNA splicing directs expression of two forms of gamma 2 phosphorylation site.

Authors:  P Whiting; R M McKernan; L L Iversen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  Increased abundance of alternatively spliced forms of D2 dopamine receptor mRNA after denervation.

Authors:  K A Neve; R L Neve; S Fidel; A Janowsky; G A Higgins
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

5.  Pre- and postsynaptic dopaminergic activities of U-86170F.

Authors:  R A Lahti; D L Evans; L M Figur; R M Huff; M W Moon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-11       Impact factor: 3.000

6.  The evolutionary divergence of neurotransmitter receptors and second-messenger pathways.

Authors:  K J Fryxell
Journal:  J Mol Evol       Date:  1995-07       Impact factor: 2.395

7.  Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone.

Authors:  J E Leysen; W Gommeren; J Mertens; W H Luyten; P J Pauwels; M Ewert; P Seeburg
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 8.  Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?

Authors:  Richard B Mailman; Vishakantha Murthy
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

9.  Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors.

Authors:  T A Reader; E Molina-Holgado; K M Dewar
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

10.  Specific [3H]raclopride binding to neostriatal dopamine D2 receptors: role of disulfide and sulfhydryl groups.

Authors:  T A Reader; E Molina-Holgado; L Lima; S Boulianne; K M Dewar
Journal:  Neurochem Res       Date:  1992-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.